Free Trial
LON:MXCT

MaxCyte (MXCT) Share Price, News & Analysis

MaxCyte logo
GBX 220 -6.00 (-2.65%)
As of 12:16 PM Eastern

About MaxCyte Stock (LON:MXCT)

Key Stats

Today's Range
220
226.90
50-Day Range
226.90
404
52-Week Range
210.36
410
Volume
33,156 shs
Average Volume
42,450 shs
Market Capitalization
£290.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions. Let’s Build Better Cells Together. To learn more, please visit www.maxcyte.com

Remove Ads
Receive MXCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter.

MXCT Stock News Headlines

MaxCyte management to meet with BTIG
MaxCyte price target lowered to $9 from $11 at Stifel
Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
MaxCyte price target lowered to $6 from $8 at BTIG
MaxCyte reports Q4 EPS (10c), consensus (12c)
See More Headlines

MXCT Stock Analysis - Frequently Asked Questions

MaxCyte's stock was trading at GBX 321.20 at the beginning of 2025. Since then, MXCT shares have decreased by 31.5% and is now trading at GBX 220.
View the best growth stocks for 2025 here
.

Shares of MXCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MaxCyte investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), EQTEC (EQT), Grafton Group (GFTU), Lloyds Banking Group (LLOY) and Marks and Spencer Group (MKS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Business Services
Current Symbol
LON:MXCT
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-45,081,271.80
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£57.52 million
Cash Flow
GBX 111.56 per share
Price / Cash Flow
1.97
Book Value
GBX 203.85 per share
Price / Book
1.08

Miscellaneous

Free Float
N/A
Market Cap
£290.41 million
Optionable
Not Optionable
Beta
1.13
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (LON:MXCT) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners